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ABSTRACT
Intermolecular couplings of simple building blocks using catalytic, stereoselective cross-Mannich reactions followed by intramolecular functional
group-pairing reactions of easily accessed variants of the Mannich products are explored as a route to skeletally diverse small molecules. The
synthetic pathway yields products having 12 different skeletons using only three steps and has the potential to enable substantial stereochemical
diversiﬁcation in the future.
Small molecules are widely used as probes in biology and
drugs in medicine.
1 One approach to their discovery involves,
in part, an upfront investment in chemistry; speciﬁcally, the
complete synthesis of a transformative small-molecule
screening collection.
2 The properties of compounds in such
a collection should possess have been discussed elsewhere,
as has a synthesis strategy that might facilitate their produc-
tion.
3 We describe an application of this “build/couple/pair”
strategy here, illustrating how intramolecular, functional
group-pairing reactions can facilitate the synthesis of skel-
etally diverse small molecules. A recent application of this
strategy proved effective in generating stereochemically and
skeletally diverse small molecules, but the requirement for
a pre-existing stereogenic center in aldehyde-containing
building blocks, which imparted face selectivity during a
Petasis reaction, limited the diversity of steroisomers. In this
case, only one face of the imine was accessible to the
nucleophile, resulting in anti-diastereoselectivity.
4 We rea-
soned that organocatalytic enantioselective additions to
electrophilic imines might increase the degree of stereo-
chemical diversity.
5 Here, we explore the use of catalytic,
enantioselective Mannich reactions using achiral aldehydes
as the nucleophile in cross-coupling reactions of highly
electrophilic imines derived from primary amines and ethyl
glyoxylate.
5b Although, in principle, recent advances in this
area would provide access to all four steroisomeric products,
we have in this study focused on the syn-diastereomeric
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Published on Web 03/10/2009products. Our initial aim was to establish conditions that
permit (1) the attachment of functional groups to the amine
and aldehyde functionalities and (2) intramolecular, func-
tional group-pairing reactions that would result in products
having diverse skeletons (Scheme 1).
We initiated the current research with commercially
available achiral reagents 1, 2, and 3 to minimize the overall
number of synthetic steps (Scheme 2). Stereochemical control
of the coupling step was achieved by using an organocatalytic
asymmetric cross-Mannich reaction.
5b (As noted, extensions
of this chemistry should exploit the full potential of
analogous enantio- and diastereoselective Mannich reactions
coupled to analogous derivatization and cyclization reactions.
Such reactions would enable the synthesis of both stere-
ochemically and skeletally diverse products, provided that
the cyclization reactions proceed with both diastereomeric
Mannich products.)
The ﬁrst reaction was a three-component, cross-Mannich
reaction using a simple aldehyde to afford the syn-product
4 stereoselectively in 72% yield. A one-pot Wittig reaction
proceeded at room temperature and gave E-alkene 5 with
high stereoselectivity in 69% yield. The E-alkene 5 was also
alkylated to give 6, 8, and 11. Benzyl compound 6 was
cyclized by using a Heck reaction to give 6/7-fused bicyclic
compound 7 in 79% yield. Allyl compound 8 was cyclized
by using another Heck reaction to give diene 9 in 42% yield
6
or a one-pot Heck/Diels-Alder-cascade sequence to give
tricyclic compound 10 with a 5/6/6-fused ring system.
The structure of 10 was conﬁrmed by X-ray crystal-
lographic analysis. A Pauson-Khand reaction of propargyl
compound 11 proceeded diastereoselectively to give azabi-
cyclo compound 12.
7
The E-alkene 5 was further transformed via one-pot
acylations to give 13 and 14 in 57% and 50% yields,
respectively (Scheme 3). Attempts to achieve microwave-
assisted intramolecular Diels-Alder reactions using furans
13 and 14 gave poor results when performed below 200 °C.
Above this temperature only diesters 15 and 16, resulting
(6) Nagasawa, K.; Ishihara, H.; Zako, Y.; Shimizu, I. J. Org. Chem.
1993, 58, 2523–2529.
(7) Gu ¨nter, M.; Gais, H.-J. J. Org. Chem. 2003, 68, 8037–8041.
Scheme 1. Build/Couple/Pair Strategy Yielding Skeletally
Diverse Small Molecules
Scheme 2. Cyclizations of N-Alkylated Intermediates
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were isolated.
8 The stereochemistry of tricyclic compound
15 was conﬁrmed by X-ray crystallographic analysis.
Next, we examined a sequence where the amine moiety
of aminoaldehyde 4 was acylated in the second step (Scheme
4). A hydrazone of 17 was transformed to give lactam 18
presumably via either an intramolecular Michael addition or
an ene reaction.
9 A nitrone derived from 17 underwent an
intramolecular 1,3-dipolar cycloaddition to give the fused
isoxazolidine 19 in 65% yield.
10 Compound 19 was obtained
as a single isomer, and the assignment of its stereochemistry
was based on NOESY experiments.
We next investigated a reaction sequence where the
aminoaldehyde 4 was acylated to form a urea in the second
step (Scheme 5).
Following urea formation and mild acidic treatment,
aminoaldehyde 4 was converted into cyclic compounds 20
and 21. The hemiaminal 20 was obtained as an inseparable
mixture of R-OH and -OH (R/ ) 4.9) and was converted
into compound 21 following treatment with aqueous TFA.
The hemiaminal 20 was also converted into the bridged
bicycle 22 by Weinreb amidation and in situ cyclization.
11
Compound 21 was converted into the tricycle 23 by a
Pictet-Spengler reaction under conditions more acidic than
those required to form 21.
12 After column chromatography,
23 was obtained as a single isomer in 67% yield. This
structure was conﬁrmed by X-ray crystallographic analysis.
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Tetrahedron 1987, 43, 5873–5886. Lactam 18a was also obtained in 11%
yield. It was probably formed via azo-hydrazo prototropy reaction of 18,
followed by 6-exo-trig cyclization.
Furthermore, a hydrazone of 17 underwent intramolecular 1,3-dipolar
cycloaddition reaction via hydrazone-azomethine imine isomerization to
afford the fused pyrazolidine 18b in 9% yield.
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3253–3263.
Scheme 3. Cyclizations of N-Acylated Intermediates
Scheme 4. Cyclizations of N-Acylaminoaldehyde Derivatives
Scheme 5. Cyclizations of N-Acylaminoaldehyde Derivatives
Org. Lett., Vol. 11, No. 7, 2009 1561In conclusion, using a syn-selective cross-Mannich reaction
in the context of the build/couple/pair strategy, we obtained
skeletally diverse small molecules with 12 different skeletons
within three steps starting from commercially available
reagents. In addition to incorporating the compounds now
available by the pathway described here into the Broad
Institute screening collection, we aim to use this strategy
with enantio- and diastereomeric products resulting from syn-
and anti-selective Mannich reactions.
5 Results of small-
molecule screens using the compounds synthesized here and
in the future will be made available on the public database
ChemBank.
13
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